Candel Therapeutics (CADL) Other Working Capital Changes (2020 - 2025)
Candel Therapeutics (CADL) posted Other Working Capital Changes of -$105000.0 for Q4 2025, up 18.6% sequentially from -$129000.0 in Q3 2025, and up 21.64% YoY from -$86319.0 in Q4 2024.
Candel Therapeutics (CADL) Other Working Capital Changes (2020 - 2025) Analysis & Trends
Candel Therapeutics has reported Other Working Capital Changes for 6 years, with the latest figure at -$105000.0 in Q4 2025.
- Quarterly Other Working Capital Changes rose 21.64% year-over-year to -$105000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$509000.0 (up 0.78% YoY) and the FY2025 annual result came in at -$509000.0, up 0.78% from the prior year.
- Other Working Capital Changes improved to -$105000.0 in Q4 2025 per CADL's latest filing, from -$129000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.5 million in Q3 2021 and troughed at -$1.2 million in Q4 2025.
- A 5-year average of $118250.0 and a median of -$17500.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes plunged 506.25% in 2022, then soared 261.54% in 2023.
- Over 5 years, Other Working Capital Changes stood at -$31000.0 in 2021, then tumbled by 293.55% to -$122000.0 in 2022, then plunged by 250.82% to -$428000.0 in 2023, then surged by 68.69% to -$134000.0 in 2024, then climbed by 21.64% to -$105000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$105000.0, -$129000.0, and -$139000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -105,000.00 |
| Dec 31, 2025 | -105,000.00 |
| Dec 31, 2025 | -105,000.00 |
| Sep 30, 2025 | -129,000.00 |
| Sep 30, 2025 | -129,000.00 |
| Sep 30, 2025 | -129,000.00 |
| Jun 30, 2025 | -139,000.00 |
| Jun 30, 2025 | -139,000.00 |
| Jun 30, 2025 | -139,000.00 |
| Mar 31, 2025 | -136,000.00 |
| Mar 31, 2025 | -136,000.00 |
| Mar 31, 2025 | -136,000.00 |
| Dec 31, 2024 | -134,000.00 |
| Dec 31, 2024 | -134,000.00 |
| Dec 31, 2024 | -134,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | -126,000.00 |
| Jun 30, 2024 | -126,000.00 |